Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

BSX | Boston Scientific Corp.

Healthcare | Medical Devices | USA | NYSE

Index	S&P 500	P/E	90.44	EPS (ttm)	0.59	Insider Own	0.50%	Shs Outstand	1.46B	Perf Week	1.51%
Market Cap	78.78B	Forward P/E	23.96	EPS next Y	2.25	Insider Trans	-5.54%	Shs Float	1.46B	Perf Month	6.68%
Income	861.00M	PEG	7.61	EPS next Q	0.48	Inst Own	93.36%	Short Float / Ratio	0.84% / 1.65	Perf Quarter	0.56%
Sales	13.40B	P/S	5.88	EPS this Y	16.79%	Inst Trans	0.92%	Short Interest	12.22M	Perf Half Y	11.57%
Book/sh	12.46	P/B	4.32	EPS next Y	12.42%	ROA	2.77%	Target Price	60.50	Perf Year	36.90%
Cash/sh	0.38	P/C	140.42	EPS next 5Y	11.88%	ROE	5.14%	52W Range	37.74 - 55.38	Perf YTD	16.27%
Dividend	-	P/FCF	52.17	EPS past 5Y	42.95%	ROI	3.17%	52W High	-2.85%	Beta	0.77
Dividend %	-	Quick Ratio	0.80	Sales past 5Y	7.36%	Gross Margin	61.46%	52W Low	42.54%	ATR	0.94
Employees	45000	Current Ratio	1.29	Sales Q/Q	10.94%	Oper. Margin	14.74%	RSI (14)	57.13	Volatility	1.58% 1.74%
Optionable	Yes	Debt/Eq	0.52	EPS Q/Q	4.73%	Profit Margin	6.43%	Rel Volume	0.91	Prev Close	53.60
Shortable	Yes	LT Debt/Eq	0.49	Earnings	Jul 27 BMO	Payout	0.00%	Avg Volume	7.40M	Price	53.80
Recom	1.41	SMA20	0.50%	SMA50	2.80%	SMA200	7.27%	Volume	6,746,141	Change	0.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight	$51
Apr-15-21	Initiated	Atlantic Equities	Overweight	$52
Sep-17-20	Initiated	Truist	Buy	$47
Sep-11-20	Initiated	Wolfe Research	Peer Perform	$46
Apr-22-20	Downgrade	SVB Leerink	Outperform → Mkt Perform	$40
Apr-01-20	Upgrade	Goldman	Neutral → Buy	$46 → $38

Show Previous Ratings

Sep-25-23 09:07AM	The Zacks Analyst Blog Highlights Amazon.com, Boeing, Regeneron, Boston Scientific and Waste Management (Zacks)
08:31AM	Boston Scientific (BSX) Set to Acquire Relievant Medsystems (Zacks)
Sep-21-23 08:15AM	What Is the Boston Scientific Foundation? (ACCESSWIRE)
06:45AM	CVS Health appoints Michael F. Mahoney to its Board of Directors (PR Newswire)
Sep-20-23 04:29PM	Boston Scientific Offers Bullish Guidance And Briefly Breaks Out (Investor's Business Daily)
11:33AM	Loading…
11:33AM	Is Boston Scientific (BSX) Priced Right? A Comprehensive Guide to Its Market Value (GuruFocus.com)
10:37AM	Boston Scientific Briefly Launches Into Buy Zone, But Investor Day Hype Cools (Investor's Business Daily)
Sep-19-23 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:56AM	6 Growth Stocks That Look Recession-Resistant, According to Morgan Stanley (Barrons.com)
09:31AM	Midday movers: Instacart, AutoZone, Target and more (Investing.com)
07:30AM	UPDATE 2-Boston Scientific to buy chronic back pain therapy maker Relievant (Reuters)
07:13AM	Boston Scientific to pay $850 mln upfront to buy Relievant Medsystems (Reuters)
07:00AM	Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc. (PR Newswire)
Sep-18-23 06:25PM	Investors urged to focus on late-cycle stock sectors amid economic uncertainty (Investing.com)
Sep-16-23 09:00PM	EVP, Human Resources Wendy Carruthers Sells 11,671 Shares of Boston Scientific Corp (BSX) (GuruFocus.com)
11:40AM	Loading…
Sep-14-23 11:40AM	PBH vs. BSX: Which Stock Is the Better Value Option? (Zacks)
Sep-13-23 05:01PM	Insider Sell: Boston Scientific Corp Chairman, President & CEO Michael Mahoney Sells ... (GuruFocus.com)
Sep-08-23 08:15AM	Boston Scientific Is Looking for a Possible Breakout (TheStreet.com)
Sep-07-23 11:16AM	Boston Scientific (BSX) WATCHMAN FLX Pro Gets FDA Approval (Zacks)
Sep-06-23 04:00PM	Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device (PR Newswire)
Sep-05-23 11:59AM	Here's Why You Should Retain Boston Scientific (BSX) Now (Zacks)
09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
08:30AM	Boston Scientific Announces 2023 Investor Day Meeting and Conference Call Discussing Third Quarter 2023 Results (PR Newswire)
Sep-01-23 10:54AM	Boston Scientific's (BSX) FARAPULSE System Study Data Positive (Zacks)
Aug-31-23 06:15AM	The Petri Dish: Boston Scientific device succeeds in trial, Sanofi vet joins Flagship (American City Business Journals)
Aug-30-23 12:26PM	Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains (InvestorPlace)
08:30AM	If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
Aug-29-23 11:40AM	PBH vs. BSX: Which Stock Should Value Investors Buy Now? (Zacks)
09:35AM	Company News for Aug 29, 2023 (Zacks)
Aug-28-23 05:24PM	S&P 500 Gains and Losses Today: Index Adds to Last Week's Advance After Powell's Comments (Investopedia) +5.97%
04:05PM	Loading…
04:05PM	Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion (Investor's Business Daily)
03:04PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
02:24PM	Boston Scientific Leads the S&P 500 (Barrons.com)
12:16PM	3M, Boston Scientific rise; Abcam, NovoCure fall, Monday, 8/28/2023 (AP Finance)
11:42AM	Boston Scientific Reports Positive Results from Atrial Fibrillation Device (Investopedia)
11:33AM	Unveiling Boston Scientific (BSX)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Aug-27-23 06:13AM	ADVENT Study of the FARAPULSE Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints (PR Newswire)
Aug-24-23 12:50PM	Top Analyst Reports for Procter & Gamble, AbbVie & Walt Disney (Zacks)
10:40AM	Boston Scientific (BSX) Expands Globally Amid FX Concerns (Zacks)
Aug-23-23 05:32PM	Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year (Investor's Business Daily)
01:01AM	EVP & Grp Pres, MedSurg & APAC Arthur Butcher Sells 6,600 Shares of Boston Scientific ... (GuruFocus.com)
Aug-15-23 09:38AM	Boston Scientific's (BSX) POLARx System Gets FDA Approval (Zacks)
Aug-08-23 04:01PM	Boston Scientific Receives FDA Approval for the POLARx Cryoablation System (PR Newswire)
Aug-04-23 04:57PM	Ozempic Is the Rage. Why That May Explain a Mysterious Medtech Stock Selloff. (Barrons.com)
04:57PM	Ozempic Is All the Rage. And That Might Explain a Mysterious Stock Selloff. (Barrons.com)
Aug-03-23 08:00AM	Building Disability Inclusion (ACCESSWIRE)
Jul-31-23 09:00AM	Privia Health Announces Changes to Board of Directors (GlobeNewswire)
Jul-29-23 07:24AM	Boston Scientific Corporation (NYSE:BSX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Jul-28-23 01:43PM	BD (BDX) Gears Up for Q3 Earnings: What's in the Offing? (Zacks)
12:42PM	Acadia Healthcare (ACHC) Q2 Earnings Beat on Higher Admissions (Zacks)
09:40AM	Women Hold a Third of S&P 500 Boards Seats With Gains in June (Bloomberg)
Jul-27-23 04:11PM	BSX Stock Near Buy Point As Boston Scientific Beats On Earnings, Raises Outlook (Investor's Business Daily)
03:48PM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
11:53AM	Boston Scientific (BSX) Q2 Earnings Beat, Margins Improve (Zacks)
09:30AM	Boston Scientific (BSX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:16AM	BSX Stock Near Buy Point: Boston Scientific Earnings Beat; Medical Giant Raises Guidance (Investor's Business Daily)
07:55AM	Boston Scientific (BSX) Q2 Earnings and Revenues Beat Estimates (Zacks)
06:48AM	Boston Scientific: Q2 Earnings Snapshot (AP Finance)
06:34AM	BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR SECOND QUARTER 2023 (PR Newswire)
Jul-26-23 11:04AM	Medical Device Stocks' Q2 Earnings on Jul 27: BSX, LH & IART (Zacks)
08:12AM	Boston Scientific plans new campus in Maple Grove (American City Business Journals)
07:46AM	5 Must-Buy Stocks Ahead of Q2 Earnings Tomorrow (Zacks)
Jul-25-23 10:01AM	Zimmer Biomet (ZBH) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release (Zacks)
02:22AM	Do You Think Boston Scientific Corporation (BSX) is Well Positioned in the Pulsed Field Ablation Market? (Insider Monkey)
Jul-24-23 11:26AM	BD (BDX) Receives FDA Nod to Address Critical Infusion Needs (Zacks)
11:24AM	Reasons to Add HealthEquity (HQY) Stock to Your Portfolio (Zacks)
09:40AM	Are Medical Stocks Lagging Boston Scientific (BSX) This Year? (Zacks)
09:00AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Jul-20-23 12:46PM	Will Boston Scientific (BSX) Beat Q2 Earnings Estimates? (Zacks)
11:39AM	Avantor's (AVTR) New Expansion Plans to Boost Workflow (Zacks)
10:02AM	Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-19-23 12:43PM	Glaukos' (GKOS) New Tie-Up to Address Chronic Eye Disease (Zacks)
11:21AM	Elevance Health (ELV) Beats on Q2 Earnings, Ups '23 Profit View (Zacks)
08:58AM	Align Technology (ALGN) to Post Q2 Earnings: What's in Store? (Zacks)
08:52AM	Viking Globals Performance, AUM, and Long-Term Stock Picks (Insider Monkey)
08:00AM	Meet Three Boston Scientific Employees on a Mission To Give Back (ACCESSWIRE)
07:00AM	Boston Scientific Insiders Sold US$6.3m Of Shares Suggesting Hesitancy (Simply Wall St.)
Jul-18-23 12:20PM	Here's Why You Should Add BD (BDX) Stock in Your Portfolio (Zacks)
12:07PM	Masimo's (MASI) Preliminary Q2 Revenues Dampened by Lower Sales (Zacks)
11:23AM	What's in Store for Thermo Fisher (TMO) in Q2 Earnings? (Zacks)
Jul-17-23 12:46PM	Inogen (INGN) Inks Buyout Agreement to Expand Product Portfolio (Zacks)
12:42PM	Intuitive Surgical (ISRG) Hits 52-Week High: What's Aiding It? (Zacks)
10:35AM	Boston Scientific (BSX) Gets FDA Nod for Vercise Software (Zacks)
Jul-14-23 12:00PM	UnitedHealth Group (UNH) Q2 Earnings Beat, Boosts '23 EPS View (Zacks)
11:01AM	Inogen's (INGN) Preliminary Q2 Revenues Dampened by Lower Sales (Zacks)
10:40AM	Thermo Fisher (TMO) Launches Diomni Enterprise Software (Zacks)
07:00AM	Boston Scientific's (NYSE:BSX) investors will be pleased with their notable 56% return over the last five years (Simply Wall St.)
Jul-13-23 11:59AM	AngioDynamics (ANGO) Q4 Earnings Lag Estimates, Revenues Top (Zacks)
11:56AM	Here's Why You Should Retain Merit Medical (MMSI) Stock for Now (Zacks)
11:42AM	CVS Health (CVS) Launches Caremark Cost Saver With a New Pact (Zacks)
11:40AM	VREX vs. BSX: Which Stock Is the Better Value Option? (Zacks)
10:50AM	How Boston Scientific Supports the LGBTQ+ Community All Year Long (ACCESSWIRE)
Jul-12-23 12:18PM	Illumina's (ILMN) Latest Launch to Boost Genomics Analysis (Zacks)
11:41AM	Alcon (ALC) Hits 52-Week High: What's Driving the Stock? (Zacks)
Jul-11-23 11:54AM	DaVita (DVA) Hits 52-Week High: What's Driving the Stock? (Zacks)
Jul-10-23 11:17AM	Alcon (ALC) Surgical End Market Grows, Vision Care Sales Rise (Zacks)
11:07AM	Here's Why Investors Should Hold Align Technology (ALGN) Now (Zacks)
10:15AM	Quest Diagnostics' (DGX) New Pact to Get Home Fertility Test (Zacks)
09:01AM	Boston Scientific Corporation's (NYSE:BSX) Intrinsic Value Is Potentially 24% Below Its Share Price (Simply Wall St.)
Jul-07-23 12:04PM	3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio (Zacks)

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Sep 20	Sale	55.00	15,867	872,685	197,992	Sep 21 04:09 PM
Carruthers Wendy	EVP, Human Resources	Sep 15	Option Exercise	14.82	6,408	94,954	68,729	Sep 15 06:34 PM
Carruthers Wendy	EVP, Human Resources	Sep 15	Sale	53.95	11,671	629,694	57,058	Sep 15 06:34 PM
Mahoney Michael F	Chairman, President & CEO	Sep 12	Option Exercise	14.67	113,355	1,662,514	1,612,277	Sep 12 05:37 PM
Mahoney Michael F	Chairman, President & CEO	Sep 12	Sale	53.91	113,355	6,110,447	1,498,922	Sep 12 05:37 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Aug 29	Sale	54.50	4,657	253,811	60,588	Aug 30 04:10 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Aug 28	Sale	53.14	13,971	742,419	65,245	Aug 30 04:10 PM
Brown Vance R	SVP, GC and Corp. Secretary	Aug 25	Sale	50.52	15,750	795,756	28,578	Aug 28 04:18 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Aug 21	Sale	50.40	6,600	332,661	11,396	Aug 22 05:09 PM
Dockendorff Charles J	Director	Aug 18	Sale	50.74	17,079	866,631	3,946	Aug 18 04:10 PM
Carruthers Wendy	EVP, Human Resources	Aug 15	Option Exercise	14.82	6,408	94,954	73,992	Aug 15 04:16 PM
Carruthers Wendy	EVP, Human Resources	Aug 15	Sale	51.30	11,671	598,678	62,321	Aug 15 04:16 PM
Monson Jonathan	SVP, Global Controller and CAO	Aug 02	Option Exercise	0.00	1,090	0	36,361	Aug 03 04:23 PM
Carruthers Wendy	EVP, Human Resources	Jul 17	Option Exercise	14.82	6,408	94,954	79,255	Jul 18 05:44 PM
Carruthers Wendy	EVP, Human Resources	Jul 17	Sale	52.85	11,671	616,774	67,584	Jul 18 05:44 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jul 01	Option Exercise	0.00	4,036	0	45,687	Jul 03 04:14 PM
Monson Jonathan	SVP, Global Controller and CAO	Jul 01	Option Exercise	0.00	729	0	35,597	Jul 03 04:14 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Jun 21	Sale	53.80	6,697	360,298	17,453	Jun 22 04:19 PM
Carruthers Wendy	EVP, Human Resources	Jun 15	Option Exercise	14.82	6,408	94,954	84,518	Jun 15 04:53 PM
Carruthers Wendy	EVP, Human Resources	Jun 15	Sale	53.24	11,671	621,359	72,847	Jun 15 04:53 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	May 16	Option Exercise	13.08	56,921	744,527	277,198	May 17 04:30 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	May 16	Sale	53.60	63,339	3,394,856	213,859	May 17 04:30 PM
Carruthers Wendy	EVP, Human Resources	May 15	Option Exercise	14.82	6,408	94,954	89,781	May 17 04:29 PM
Carruthers Wendy	EVP, Human Resources	May 15	Sale	53.49	11,671	624,333	78,110	May 17 04:29 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	May 02	Option Exercise	12.89	30,688	395,568	95,670	May 03 04:56 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	May 02	Option Exercise	0.00	2,101	0	25,082	May 03 04:56 PM
Sorenson John Bradley	EVP, Global Operations	May 02	Option Exercise	0.00	4,203	0	38,606	May 03 04:56 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	May 02	Sale	52.49	83,401	4,377,543	12,269	May 03 04:56 PM
Carruthers Wendy	EVP, Human Resources	Apr 17	Option Exercise	14.82	6,408	94,954	95,044	Apr 18 04:30 PM
Carruthers Wendy	EVP, Human Resources	Apr 17	Sale	51.96	11,671	606,423	83,373	Apr 18 04:30 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Apr 05	Sale	50.40	4,903	247,111	78,673	Apr 06 04:26 PM
Monson Jonathan	SVP, Global Controller and CAO	Mar 31	Option Exercise	12.89	5,000	64,450	39,868	Mar 31 04:30 PM
Monson Jonathan	SVP, Global Controller and CAO	Mar 31	Sale	50.00	5,000	250,000	34,868	Mar 31 04:30 PM
Sorenson John Bradley	EVP, Global Operations	Mar 31	Sale	50.00	4,000	200,000	34,403	Mar 31 04:30 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Mar 30	Sale	49.60	4,903	243,189	83,576	Mar 31 04:29 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Mar 23	Sale	47.97	6,703	321,543	22,981	Mar 24 04:17 PM
Carruthers Wendy	EVP, Human Resources	Mar 15	Option Exercise	14.82	6,408	94,954	100,307	Mar 16 04:28 PM
Carruthers Wendy	EVP, Human Resources	Mar 15	Sale	47.60	11,671	555,575	88,636	Mar 16 04:28 PM
Brennan Daniel J.	EVP and CFO	Mar 02	Sale	46.66	30,000	1,399,914	225,958	Mar 02 05:01 PM
Brennan Daniel J.	EVP and CFO	Mar 01	Option Exercise	15.69	45,610	715,794	331,568	Mar 02 05:01 PM
Monson Jonathan	SVP, Global Controller and CAO	Mar 01	Option Exercise	12.89	5,000	64,450	39,868	Mar 02 04:59 PM
Brennan Daniel J.	EVP and CFO	Mar 01	Sale	46.64	75,610	3,526,337	255,958	Mar 02 05:01 PM
Monson Jonathan	SVP, Global Controller and CAO	Mar 01	Sale	46.66	5,000	233,315	34,868	Mar 02 04:59 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 22	Sale	46.10	3,340	153,974	88,479	Feb 22 04:55 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 21	Option Exercise	0.00	1,714	0	30,445	Feb 22 04:54 PM
Carruthers Wendy	EVP, Human Resources	Feb 21	Option Exercise	0.00	1,558	0	94,590	Feb 22 04:54 PM
Brennan Daniel J.	EVP and CFO	Feb 21	Option Exercise	0.00	3,661	0	287,582	Feb 22 04:53 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 21	Option Exercise	0.00	2,804	0	95,411	Feb 22 04:55 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 21	Option Exercise	0.00	623	0	35,120	Feb 22 04:55 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 21	Option Exercise	0.00	1,714	0	65,975	Feb 22 04:56 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21	Option Exercise	0.00	779	0	41,880	Feb 22 04:54 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 21	Option Exercise	0.00	3,895	0	222,200	Feb 22 04:54 PM
Sorenson John Bradley	EVP, Global Operations	Feb 21	Option Exercise	0.00	1,091	0	38,901	Feb 22 04:56 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 21	Sale	46.32	2,313	107,138	91,819	Feb 22 04:55 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 18	Option Exercise	0.00	2,817	0	93,609	Feb 21 04:19 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 18	Option Exercise	0.00	3,706	0	220,134	Feb 21 04:19 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 18	Option Exercise	0.00	637	0	34,751	Feb 21 04:19 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18	Option Exercise	0.00	1,186	0	38,351	Feb 21 04:19 PM
Brennan Daniel J.	EVP and CFO	Feb 18	Option Exercise	0.00	3,706	0	285,565	Feb 21 04:16 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 18	Option Exercise	0.00	2,001	0	65,420	Feb 21 04:20 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 18	Option Exercise	0.00	741	0	41,319	Feb 21 04:16 PM
Carruthers Wendy	EVP, Human Resources	Feb 18	Option Exercise	0.00	1,853	0	93,854	Feb 21 04:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 18	Option Exercise	0.00	2,372	0	29,783	Feb 21 04:16 PM
Mahoney Michael F	Chairman, President & CEO	Feb 18	Option Exercise	0.00	16,307	0	1,848,710	Feb 21 04:19 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17	Option Exercise	0.00	18,333	0	1,840,534	Feb 21 04:19 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 17	Option Exercise	0.00	2,500	0	64,867	Feb 21 04:15 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17	Option Exercise	0.00	2,833	0	28,668	Feb 21 04:16 PM
Carruthers Wendy	EVP, Human Resources	Feb 17	Option Exercise	0.00	2,250	0	92,999	Feb 21 04:16 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17	Option Exercise	0.00	1,000	0	40,872	Feb 21 04:16 PM
Brennan Daniel J.	EVP and CFO	Feb 17	Option Exercise	0.00	4,583	0	283,892	Feb 21 04:16 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17	Option Exercise	0.00	1,500	0	37,850	Feb 21 04:19 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 17	Option Exercise	0.00	1,000	0	34,535	Feb 21 04:19 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17	Option Exercise	0.00	4,166	0	218,484	Feb 21 04:19 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17	Option Exercise	0.00	3,333	0	93,873	Feb 21 04:19 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17	Sale	46.35	2,061	95,527	90,792	Feb 21 04:19 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16	Option Exercise	0.00	16,264	0	1,829,415	Feb 21 04:19 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16	Option Exercise	0.00	1,838	0	40,440	Feb 21 04:16 PM
Carruthers Wendy	EVP, Human Resources	Feb 16	Option Exercise	0.00	2,050	0	91,659	Feb 21 04:16 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16	Option Exercise	0.00	2,545	0	26,964	Feb 21 04:16 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 16	Option Exercise	0.00	2,262	0	63,677	Feb 21 04:15 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16	Option Exercise	0.00	2,970	0	92,858	Feb 21 04:19 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 16	Option Exercise	0.00	990	0	33,991	Feb 21 04:19 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16	Option Exercise	0.00	1,272	0	36,931	Feb 21 04:19 PM
Brennan Daniel J.	EVP and CFO	Feb 16	Option Exercise	0.00	4,243	0	280,559	Feb 21 04:16 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16	Option Exercise	0.00	3,960	0	216,124	Feb 21 04:19 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16	Sale	46.79	1,409	65,927	90,540	Feb 21 04:19 PM
Brennan Daniel J.	EVP and CFO	Feb 15	Option Exercise	4.77	11,725	55,957	285,107	Feb 16 07:15 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 15	Option Exercise	0.00	1,846	0	25,238	Feb 16 07:15 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 15	Option Exercise	0.00	923	0	38,925	Feb 16 07:15 PM
Sorenson John Bradley	EVP, Global Operations	Feb 15	Option Exercise	0.00	1,200	0	36,207	Feb 16 07:17 PM
Monson Jonathan	SVP, Global Controller and CAO	Feb 15	Option Exercise	0.00	739	0	33,341	Feb 16 07:17 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 15	Option Exercise	0.00	2,031	0	90,510	Feb 16 07:17 PM
Mahoney Michael F	Chairman, President & CEO	Feb 15	Option Exercise	0.00	18,457	0	1,821,337	Feb 16 07:17 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 15	Option Exercise	0.00	4,615	0	214,442	Feb 16 07:17 PM
Carruthers Wendy	EVP, Human Resources	Feb 15	Option Exercise	0.00	1,661	0	90,346	Feb 16 07:17 PM
Thepaut Eric Francis Yves	EVP & Pres, Eur, Mid-East, Afr	Feb 15	Option Exercise	0.00	1,846	0	62,484	Feb 16 07:18 PM
Brennan Daniel J.	EVP and CFO	Feb 15	Sale	47.14	7,572	356,927	276,316	Feb 16 07:15 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03	Option Exercise	16.58	15,034	249,206	50,392	Feb 06 04:41 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03	Sale	48.74	27,000	1,316,037	23,392	Feb 06 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 04	Sale	46.38	6,751	313,123	88,479	Jan 04 04:21 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX | Boston Scientific Corp.

Upgrade your FINVIZ experience